peptide elongation factor 2 has been researched along with adenine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Foley, BT; Moehring, JM; Moehring, TJ | 1 |
| Donner, DB; Dunbar, JD; Guo, D; Han, HM; Jaffe, EA; Kolesnick, R; Marino, MW; Matsushita, M; Nairn, AC; Ngaiza, JR; Wu, LW; Zhang, Y | 1 |
2 other study(ies) available for peptide elongation factor 2 and adenine
| Article | Year |
|---|---|
A mutation in codon 717 of the CHO-K1 elongation factor 2 gene prevents the first step in the biosynthesis of diphthamide.
Topics: Adenine; Amino Acid Sequence; Animals; Arginine; Base Sequence; CHO Cells; Codon; Cricetinae; Glycine; Guanine; Histidine; Homozygote; Molecular Sequence Data; Mutation; Peptide Elongation Factor 2; Peptide Elongation Factors; Polymorphism, Restriction Fragment Length | 1992 |
Inhibition of tumor necrosis factor signal transduction in endothelial cells by dimethylaminopurine.
Topics: Adenine; Animals; Cattle; Endothelium, Vascular; Enzyme Inhibitors; Eukaryotic Initiation Factor-4E; Histamine; Peptide Elongation Factor 2; Peptide Elongation Factors; Peptide Initiation Factors; Phosphorylation; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins c-raf; Signal Transduction; Tumor Necrosis Factor-alpha | 1996 |